Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    21610270 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Atherosclerosis Underlying Development Assessed by Intima-Media Thickness in Patients on Rimonabant
Conditions: Carotid Artery Plaque;   Arteriosclerosis;   Obesity;   Metabolic Syndrome X
Interventions: Drug: Rimonabant;   Drug: Placebo (for Rimonabant)

Study has passed its completion date and status has not been verified in more than two years.